L
Lipocine
LPCN
5.02000
USD
0
(0.00%)
مغلق
حجم التداول
612
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
29,092,794
العنوان: Lipocine
القطاع: Healthcare
الصناعة: Biotechnology
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.